$86.43
-1.58[-1.80%]
At close: Apr 26
$86.43
0[0.00%]
After Hours: 4:00PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Date Announced | ticker | Company Name | Period | Period Year | Min EPS | Max EPS | Estimate | Min Rev | Max Rev | Revenue Estimate | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|
04/25/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.75 | $6.60B | $6.60B | $6.52B | Get Alert |
04/25/2024 | EW | Edwards Lifesciences | Q2 | 2024 | $0.67 | $0.71 | $0.70 | $1.62B | $1.70B | $1.64B | Get Alert |
02/06/2024 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.76 | $6.30B | $6.60B | $6.48B | Get Alert |
02/06/2024 | EW | Edwards Lifesciences | Q1 | 2024 | $0.62 | $0.66 | $0.66 | $1.53B | $1.61B | $1.56B | Get Alert |
12/07/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.47 | $2.53 | $2.51 | $5.90B | $6.10B | $5.97B | Get Alert |
12/07/2023 | EW | Edwards Lifesciences | FY | 2024 | $2.70 | $2.80 | $2.80 | $6.30B | $6.60B | $6.51B | Get Alert |
10/25/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.92B | $6.08B | $6.00B | Get Alert |
10/25/2023 | EW | Edwards Lifesciences | Q4 | 2023 | $0.60 | $0.66 | $0.68 | $1.45B | $1.53B | $1.54B | Get Alert |
07/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.50 | $2.60 | $2.55 | $5.90B | $6.10B | $5.96B | Get Alert |
07/26/2023 | EW | Edwards Lifesciences | Q3 | 2023 | $0.55 | $0.61 | $0.63 | $1.44B | $1.52B | $1.47B | Get Alert |
04/26/2023 | EW | Edwards Lifesciences | Q2 | 2023 | $0.62 | $0.68 | $0.63 | $1.48B | $1.56B | $1.46B | Get Alert |
04/26/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.48 | $2.60 | $2.52 | $6.00B | $6.00B | $5.85B | Get Alert |
01/31/2023 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.50 | $5.60B | $6.00B | $5.78B | Get Alert |
01/31/2023 | EW | Edwards Lifesciences | Q1 | 2023 | $0.58 | $0.64 | $0.59 | $1.37B | $1.45B | $1.37B | Get Alert |
12/08/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.45 | $5.35B | $5.35B | $5.36B | Get Alert |
12/08/2022 | EW | Edwards Lifesciences | FY | 2023 | $2.45 | $2.60 | $2.52 | $5.60B | $6.00B | $5.71B | Get Alert |
10/27/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.40 | $2.50 | $2.51 | $5.35B | $5.35B | $5.47B | Get Alert |
07/28/2022 | EW | Edwards Lifesciences | Q3 | 2022 | $0.58 | $0.66 | $0.65 | $1.30B | $1.37B | $1.44B | Get Alert |
07/28/2022 | EW | Edwards Lifesciences | FY | 2022 | $2.50 | $2.50 | $2.56 | $5.35B | $5.55B | $5.71B | Get Alert |
The last reported Earnings numbers were from April 25, 2024 for the full year 2024 and was for an earnings per share guidance in the range of $2.70 and $2.80 versus the estimated EPS of $2.75.
Browse guidance and forecast on all stocks.